z-logo
open-access-imgOpen Access
Validation of the circulating monocyte being representative of the cholesterol-loaded macrophage: biomediator activity.
Author(s) -
Sridevi Devaraj,
Ishwarlal Jialal
Publication year - 2008
Publication title -
pubmed
Language(s) - English
Resource type - Journals
ISSN - 0003-9985
DOI - 10.5858/2008-132-1432-votcmb
Subject(s) - monocyte , macrophage , cd14 , hyperlipidemia , cholesterol , medicine , endocrinology , inflammation , tumor necrosis factor alpha , integrin alpha m , interleukin , superoxide , interleukin 6 , immunology , cytokine , chemistry , biochemistry , in vitro , receptor , diabetes mellitus , enzyme
Inflammation is pivotal to atherosclerosis. The monocyte-macrophage, a crucial cell in atherogenesis, is present during all stages of atherosclerosis. However, there is a paucity of data comparing circulating monocytes to cholesterol-laden macrophages (foam cells), with regard to their atherogenic properties, especially in subjects with established risk factors such as hyperlipidemia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here